Annual Cash & Cash Equivalents
$185.08 M
-$155.31 M-45.63%
December 31, 2023
Summary
- As of February 24, 2025, RNA annual cash & cash equivalents is $185.08 million, with the most recent change of -$155.31 million (-45.63%) on December 31, 2023.
- During the last 3 years, RNA annual cash & cash equivalents has fallen by -$136.38 million (-42.42%).
- RNA annual cash & cash equivalents is now -45.63% below its all-time high of $340.40 million, reached on December 31, 2022.
Performance
RNA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$370.19 M
-$205.56 M-35.70%
September 1, 2024
Summary
- As of February 24, 2025, RNA quarterly cash and cash equivalents is $370.19 million, with the most recent change of -$205.56 million (-35.70%) on September 1, 2024.
- Over the past year, RNA quarterly cash and cash equivalents has stayed the same.
- RNA quarterly cash and cash equivalents is now -35.70% below its all-time high of $575.75 million, reached on June 30, 2024.
Performance
RNA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RNA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.6% | 0.0% |
| 3 y3 years | -42.4% | -9.7% |
| 5 y5 years | +5889.7% | - |
RNA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.6% | at low | -35.7% | +332.2% |
| 5 y | 5-year | -45.6% | +95.7% | -35.7% | +332.2% |
| alltime | all time | -45.6% | +5889.7% | -35.7% | +332.2% |
Avidity Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $370.19 M(-35.7%) |
| Jun 2024 | - | $575.75 M(+22.1%) |
| Mar 2024 | - | $471.40 M(+154.7%) |
| Dec 2023 | $185.08 M(-45.6%) | $185.08 M(+116.1%) |
| Sep 2023 | - | $85.65 M(-44.3%) |
| Jun 2023 | - | $153.88 M(+29.6%) |
| Mar 2023 | - | $118.71 M(-65.1%) |
| Dec 2022 | $340.40 M | $340.40 M(+136.9%) |
| Sep 2022 | - | $143.70 M(+14.9%) |
| Jun 2022 | - | $125.11 M(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $139.26 M(-56.5%) |
| Dec 2021 | $320.45 M(-0.3%) | $320.45 M(-21.8%) |
| Sep 2021 | - | $410.01 M(+48.3%) |
| Jun 2021 | - | $276.42 M(-8.2%) |
| Mar 2021 | - | $301.27 M(-6.3%) |
| Dec 2020 | $321.46 M(+239.9%) | $321.46 M(-5.8%) |
| Sep 2020 | - | $341.14 M(-3.2%) |
| Jun 2020 | - | $352.45 M(+297.1%) |
| Mar 2020 | - | $88.75 M(-6.2%) |
| Dec 2019 | $94.58 M(+2960.8%) | $94.58 M |
| Dec 2018 | $3.09 M | - |
FAQ
- What is Avidity Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Avidity Biosciences?
- What is Avidity Biosciences annual cash & cash equivalents year-on-year change?
- What is Avidity Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Avidity Biosciences?
- What is Avidity Biosciences quarterly cash and cash equivalents year-on-year change?
What is Avidity Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of RNA is $185.08 M
What is the all time high annual cash & cash equivalents for Avidity Biosciences?
Avidity Biosciences all-time high annual cash & cash equivalents is $340.40 M
What is Avidity Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, RNA annual cash & cash equivalents has changed by -$155.31 M (-45.63%)
What is Avidity Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RNA is $370.19 M
What is the all time high quarterly cash and cash equivalents for Avidity Biosciences?
Avidity Biosciences all-time high quarterly cash and cash equivalents is $575.75 M
What is Avidity Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, RNA quarterly cash and cash equivalents has changed by $0.00 (0.00%)